{"entity":{"type":"insider","cik":"0001704234","url":"/insider/0001704234","json_url":"/insider/0001704234.json","name":"Doogan Declan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":73,"n_filings":17,"first":"2018-01-12","last":"2022-02-11","span_basis":"filed_date"},"name_variants":[{"name":"Doogan Declan","source":"filing","n_filings":17,"first_seen":"2018-01-12","last_seen":"2022-02-11"}],"transactions":[{"id":4186472,"accession":"0001562180-21-007370","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-007370","line_url":"/filing/0001562180-21-007370","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24525.0,"shares_display":"24,525","price_per_share":112.8005294556575,"price_display":"112.80","price_state":"stated","total_value":2766432.9849,"total_display":"2,766,432.98","total_whole":"2,766,433","shares_owned_after":882147.0,"shares_owned_after_display":"882,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-01","scope":"insider","n_lines":2},{"id":4265345,"accession":"0001562180-21-007138","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001562180-21-007138","line_url":"/filing/0001562180-21-007138","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37740.0,"shares_display":"37,740","price_per_share":116.65037200847907,"price_display":"116.65","price_state":"stated","total_value":4402385.0396,"total_display":"4,402,385.04","total_whole":"4,402,385","shares_owned_after":902246.0,"shares_owned_after_display":"902,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-17","scope":"insider","n_lines":3},{"id":6726976,"accession":"0001562180-22-001435","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-001435","line_url":"/filing/0001562180-22-001435","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25508.0,"shares_display":"25,508","price_per_share":68.73459551513251,"price_display":"68.73","price_state":"stated","total_value":1753282.0624,"total_display":"1,753,282.06","total_whole":"1,753,282","shares_owned_after":676002.0,"shares_owned_after_display":"676,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2022-02-11","scope":"insider","n_lines":2},{"id":3028746,"accession":"0001562180-20-004574","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-20-004574","line_url":"/filing/0001562180-20-004574","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":68.21598601333334,"price_display":"68.22","price_state":"stated","total_value":4092959.1608,"total_display":"4,092,959.16","total_whole":"4,092,959","shares_owned_after":651510.0,"shares_owned_after_display":"651,510","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider","n_lines":4},{"id":6726969,"accession":"0001562180-22-001435","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-001435","line_url":"/filing/0001562180-22-001435","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15798.0,"shares_display":"15,798","price_per_share":68.10162563615647,"price_display":"68.10","price_state":"stated","total_value":1075869.4818,"total_display":"1,075,869.48","total_whole":"1,075,869","shares_owned_after":333912.0,"shares_owned_after_display":"333,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2022-02-11","scope":"insider","n_lines":2},{"id":3028729,"accession":"0001562180-20-004574","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-004574","line_url":"/filing/0001562180-20-004574","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":66.734885985,"price_display":"66.73","price_state":"stated","total_value":5338790.8788,"total_display":"5,338,790.88","total_whole":"5,338,791","shares_owned_after":720502.0,"shares_owned_after_display":"720,502","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-17","scope":"insider","n_lines":4},{"id":6571833,"accession":"0001562180-22-001434","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-001434","line_url":"/filing/0001562180-22-001434","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25914.0,"shares_display":"25,914","price_per_share":65.78490484680096,"price_display":"65.78","price_state":"stated","total_value":1704750.0242,"total_display":"1,704,750.02","total_whole":"1,704,750","shares_owned_after":347246.0,"shares_owned_after_display":"347,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2022-02-11","scope":"insider","n_lines":2},{"id":2671554,"accession":"0001562180-20-004471","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-20-004471","line_url":"/filing/0001562180-20-004471","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":64.73066016,"price_display":"64.73","price_state":"stated","total_value":5178452.8128,"total_display":"5,178,452.81","total_whole":"5,178,453","shares_owned_after":791916.0,"shares_owned_after_display":"791,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-12","scope":"insider","n_lines":4},{"id":6571828,"accession":"0001562180-22-001434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-001434","line_url":"/filing/0001562180-22-001434","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25039.0,"shares_display":"25,039","price_per_share":64.57417894883982,"price_display":"64.57","price_state":"stated","total_value":1616872.8667,"total_display":"1,616,872.87","total_whole":"1,616,873","shares_owned_after":360580.0,"shares_owned_after_display":"360,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2022-02-11","scope":"insider","n_lines":2},{"id":2671544,"accession":"0001562180-20-004471","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-004471","line_url":"/filing/0001562180-20-004471","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":63.40749661,"price_display":"63.41","price_state":"stated","total_value":5072599.7288,"total_display":"5,072,599.73","total_whole":"5,072,600","shares_owned_after":846002.0,"shares_owned_after_display":"846,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-12","scope":"insider","n_lines":4},{"id":8118884,"accession":"0001209191-19-024835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-024835","line_url":"/filing/0001209191-19-024835#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":61.92,"price_display":"61.92","price_state":"stated","total_value":3096000.0,"total_display":"3,096,000.00","total_whole":"3,096,000","shares_owned_after":926002.0,"shares_owned_after_display":"926,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-16","filed_date":"2019-04-16","scope":"insider"},{"id":8118881,"accession":"0001209191-19-024835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-024835","line_url":"/filing/0001209191-19-024835#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38825.0,"shares_display":"38,825","price_per_share":53.92,"price_display":"53.92","price_state":"stated","total_value":2093444.0,"total_display":"2,093,444.00","total_whole":"2,093,444","shares_owned_after":976002.0,"shares_owned_after_display":"976,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-12","filed_date":"2019-04-16","scope":"insider"},{"id":8754297,"accession":"0001209191-19-021354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-021354","line_url":"/filing/0001209191-19-021354#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5824.0,"shares_display":"5,824","price_per_share":53.72,"price_display":"53.72","price_state":"stated","total_value":312865.28,"total_display":"312,865.28","total_whole":"312,865","shares_owned_after":1014827.0,"shares_owned_after_display":"1,014,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-26","filed_date":"2019-03-26","scope":"insider"},{"id":8754293,"accession":"0001209191-19-021354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-021354","line_url":"/filing/0001209191-19-021354#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5351.0,"shares_display":"5,351","price_per_share":53.66,"price_display":"53.66","price_state":"stated","total_value":287134.66,"total_display":"287,134.66","total_whole":"287,135","shares_owned_after":1020651.0,"shares_owned_after_display":"1,020,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-22","filed_date":"2019-03-26","scope":"insider"},{"id":7977466,"accession":"0001209191-19-015151","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-015151","line_url":"/filing/0001209191-19-015151","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50595.0,"shares_display":"50,595","price_per_share":47.169067101492246,"price_display":"47.17","price_state":"stated","total_value":2386518.95,"total_display":"2,386,518.95","total_whole":"2,386,519","shares_owned_after":1026002.0,"shares_owned_after_display":"1,026,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-01","scope":"insider","n_lines":2},{"id":7977459,"accession":"0001209191-19-015151","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-015151","line_url":"/filing/0001209191-19-015151","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50429.0,"shares_display":"50,429","price_per_share":45.33904876162526,"price_display":"45.34","price_state":"stated","total_value":2286402.89,"total_display":"2,286,402.89","total_whole":"2,286,403","shares_owned_after":1076597.0,"shares_owned_after_display":"1,076,597","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-27","filed_date":"2019-03-01","scope":"insider","n_lines":4},{"id":7788034,"accession":"0001209191-19-013671","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-013671","line_url":"/filing/0001209191-19-013671","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20896.0,"shares_display":"20,896","price_per_share":44.312392802450226,"price_display":"44.31","price_state":"stated","total_value":925951.76,"total_display":"925,951.76","total_whole":"925,952","shares_owned_after":401058.0,"shares_owned_after_display":"401,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-26","scope":"insider","n_lines":2},{"id":7788030,"accession":"0001209191-19-013671","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-013671","line_url":"/filing/0001209191-19-013671","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34377.0,"shares_display":"34,377","price_per_share":45.34876719899933,"price_display":"45.35","price_state":"stated","total_value":1558954.57,"total_display":"1,558,954.57","total_whole":"1,558,955","shares_owned_after":421954.0,"shares_owned_after_display":"421,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-26","scope":"insider","n_lines":3},{"id":7788024,"accession":"0001209191-19-013671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-013671","line_url":"/filing/0001209191-19-013671","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21625.0,"shares_display":"21,625","price_per_share":44.748289017341044,"price_display":"44.75","price_state":"stated","total_value":967681.75,"total_display":"967,681.75","total_whole":"967,682","shares_owned_after":442288.0,"shares_owned_after_display":"442,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-22","filed_date":"2019-02-26","scope":"insider","n_lines":2},{"id":8597000,"accession":"0001209191-19-011732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-011732","line_url":"/filing/0001209191-19-011732#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":45.51,"price_display":"45.51","price_state":"stated","total_value":63714.0,"total_display":"63,714.00","total_whole":"63,714","shares_owned_after":1113924.0,"shares_owned_after_display":"1,113,924","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-20","scope":"insider"},{"id":8596998,"accession":"0001209191-19-011732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-011732","line_url":"/filing/0001209191-19-011732#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":678.0,"shares_display":"678","price_per_share":45.42,"price_display":"45.42","price_state":"stated","total_value":30794.76,"total_display":"30,794.76","total_whole":"30,795","shares_owned_after":1115324.0,"shares_owned_after_display":"1,115,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-20","scope":"insider"},{"id":8231761,"accession":"0001209191-19-010219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-010219","line_url":"/filing/0001209191-19-010219#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6158.0,"shares_display":"6,158","price_per_share":44.24,"price_display":"44.24","price_state":"stated","total_value":272429.92,"total_display":"272,429.92","total_whole":"272,430","shares_owned_after":1116002.0,"shares_owned_after_display":"1,116,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-13","filed_date":"2019-02-14","scope":"insider"},{"id":8231757,"accession":"0001209191-19-010219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-010219","line_url":"/filing/0001209191-19-010219#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704234","owner_name":"Doogan Declan","owner_display_name":"Doogan Declan","owner_url":"/insider/0001704234","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33842.0,"shares_display":"33,842","price_per_share":44.32,"price_display":"44.32","price_state":"stated","total_value":1499877.44,"total_display":"1,499,877.44","total_whole":"1,499,877","shares_owned_after":1122160.0,"shares_owned_after_display":"1,122,160","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider"}],"collapsed":true,"next_cursor":"2019-02-12|8231757","ledger_fault":false,"count":{"value":73,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":73,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":73},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689813","name":"Biohaven Pharmaceutical Holding Co Ltd.","url":"/issuer/0001689813","role":"Director","n_filings":17,"first_seen":"2018-01-12","last_seen":"2022-02-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704234","retrieved_at":"2026-08-24T19:50:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}